Getting to the heart of COVID-19 vaccination and its cardiovascular risks

After mRNA vaccination, adults under 40 have a slightly greater chance of developing myocarditis or pericarditis, yet the vaccine’s benefits outweigh the risks, according to the American Journal of Preventive Medicine A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis

Read More


Long COVID and pulmonary fibrosis better understood thanks to innovative techniques

An international team of researchers has revealed how scarring occurs in Long-COVID and pulmonary fibrosis using innovative blood biomarkers and X-ray technology. This study, published in The Lancet – eBioMedicine, contributes to the knowledge on the pathophysiology of severe COVID-19 and thus its treatment. Long-COVID syndrome, or the origin of the long-term consequences of SARS-CoV-2

Read More


University of Michigan researchers engineer a drug derived from bananas showing promise in fighting deadly viruses and SARS-CoV-2

A banana a day may not keep the doctor away, but a substance originally found in bananas and carefully edited by scientists could someday fight off a wide range of viruses, new research suggests. And the process used to create the virus-fighting form may help scientists develop even more drugs, by harnessing the “sugar code”

Read More


For American Society of Anesthesiologists statins lower COVID-19 severity and risk of death

Commonly used cholesterol-lowering statins may reduce the risk of death and severity of COVID-19 disease, suggests a study of more than 38,000 patients being presented at the Anesthesiology 2022 annual meeting. “While there is no ‘magic bullet’ to help patients who are very ill with COVID-19, statins decrease inflammation, which may help reduce the severity

Read More


The Philippines Department of Health said first new cases of XBB and XBC Covid-19 Omicron variants were detected. 

In a media briefing, Health Officer-in-Charge Maria Rosario Vergeire said that based on the latest whole genomic sequencing run of the agency, a total of 81 XBB subvariant cases have been detected in two regions in the country.  Vergeire also said that there were 193 XBC subvariant cases found in 11 out of 17 regions

Read More


In Singapore XBB seems to be more prevalent in the COVID-naive and those originally infected in the Delta and pre-Delta era

Singapore’s Health Minister, Ong Ye Kung, has said that he expects the current XBB SARS-CoV-2 wave to peak in mid-November 2022.  In an assured press conference, Singapore’s Health Minister said he expects the XBB to crest at about 15,000 daily cases on average. Covid case levels in Singapore are currently averaging around 8,500 a day.

Read More


Intranasal COVID-19 AstraZeneca vaccine candidate’s Phase I trial clinical data highlights need for further development

Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the safety and immune response of an intranasally-administered vaccine against COVID-19.The study was performed at the University in collaboration with AstraZeneca and used the same vaccine based on the ChAdOx1 adenovirus vector, as is already licensed for

Read More